未登录

M

Meryl Brod

The Brod Group

H指数:40

被引数:7,042

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Patient-reported outcomes in palopegteriparatide-treated adults with hypoparathyroidism: PaTH Forward trial extension

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

IF5.1

2026-01-010

OA

Impact of cohorting carbapenem-resistant Acinetobacter baumannii (CRAB) patients combined with enhanced environmental cleaning on CRAB bloodstream infections: a prospective surveillance-based study

加强环境清洁与隔离耐碳青霉烯鲍曼不动杆菌（CRAB）患者对CRAB血流感染的影响：一项基于前瞻性监测的研究

Journal of Hospital Infection

IF3.1

2025-06-060

PRE

Development and validation of an eating behavior patient-reported outcome measure in people living with obesity or overweight

超重或肥胖患者报告的进食行为结局指标的制定与验证

IF4.7

2025-05-280

OA

Characterizing Patient-Reported Cognitive Symptoms and Their Impact on Daily Life in Narcolepsy Type 1

表征发作性睡病1型患者报告的认知症状及其对日常生活的影响

IF4.9

2025-05-190

PRE

Development and validation of the Child Hemophilia Treatment Experience Measure: A new observer-reported outcome measure

IF3

2024-10-100

OA

Weekly Somapacitan in GH Deficiency: 4-Year Efficacy, Safety, and Treatment/Disease Burden Results From REAL 3

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

IF5.1

2023-03-3019

OA

Content validation of the SF-36v2® Health Survey Acute for use in hypoparathyroidism

QUALITY OF LIFE RESEARCH

IF2.7

2023-02-090

OAAI

Psychometric Validation of the Growth Hormone Deficiency-Child Treatment Burden Measure (GHD-CTB) and the Growth Hormone Deficiency-Parent Treatment Burden Measure (GHD-PTB)

PHARMACOECONOMICS-OPEN

IF2.1

2022-10-184

OAAI

Development and Validation of the Diabetes Pen Experience Measure: A New Patient-Reported Outcome Measure

JOURNAL OF DIABETES SCIENCE AND TECHNOLOGY

IF3.7

2022-03-140

OAAI

Effective GH Replacement With Once-weekly Somapacitan vs Daily GH in Children with GHD: 3-year Results From REAL 3

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

IF5.1

2021-12-2931

OA

Letter to the Editor From Savendahl et al.: Weekly Lonapegsomatropin in Treatment-Naive Children With Growth Hormone Deficiency: The Phase 3 heiGHt Trial

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

IF5.1

2021-10-092

OA

Psychometric validation of the Hypoparathyroidism Patient Experience Scales (HPES)

JOURNAL OF PATIENT-REPORTED OUTCOMES

IF2.9

2021-08-1010

OAAI

A qualitative study of the impacts of having an infant or young child with achondroplasia on parent well-being

ORPHANET JOURNAL OF RARE DISEASES

IF3.5

2021-08-066

OAAI

PaTH Forward: A Randomized, Double-Blind, Placebo-Controlled Phase 2 Trial of TransCon PTH in Adult Hypoparathyroidism

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

IF5.1

2021-08-0437

OA

Assessing the impacts of having a child with achondroplasia on parent well-being (August, 10.1007/s11136-020-02594-3, 2020)

QUALITY OF LIFE RESEARCH

IF2.7

2020-10-300

OAAI

Living with hypoparathyroidism: development of the Hypoparathyroidism Patient Experience Scale-Impact (HPES-Impact)

QUALITY OF LIFE RESEARCH

IF2.7

2020-08-2410

OAAI

Assessing the impacts of having a child with achondroplasia on parent well-being

QUALITY OF LIFE RESEARCH

IF2.7

2020-08-1613

OAAI

Understanding the burden of illness of excessive daytime sleepiness associated with obstructive sleep apnea: a qualitative study

了解与阻塞性睡眠呼吸暂停相关的白天过度嗜睡的疾病负担: 定性研究

HEALTH AND QUALITY OF LIFE OUTCOMES

IF3.4

2020-05-0733

OAAI

Once-Weekly Somapacitan vs Daily GH in Children With GH Deficiency: Results From a Randomized Phase 2 Trial

GH缺乏症儿童每周一次的Somapacitan vs每日GH: 一项随机2期试验的结果

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

IF5.1

2020-01-0947

OAAI

Impact of excessive sleepiness associated with obstructive sleep apnea on work productivity in the United States

EUROPEAN RESPIRATORY JOURNAL

IF21

2019-11-216

PRE